Business

President Trump forced companies and investors worldwide in 2025 to adapt to ongoing policy and market uncertainty, and some forecasters warned a weaker dollar could be a wild card.

European governments raced to reassure pharmaceutical companies and secure investment after heightened U.S. tariff pressure under President Trump, but firms said momentum had shifted elsewhere.

Fund managers and analysts predicted a strong 2026 for global stock markets driven by AI-fueled gains, rising corporate profits and expected Fed rate cuts, though many warned of bubble risks.